biopharmaceutical manufacturing

biopharmaceutical manufacturing

featured image of Boost mRNA Manufacturing with Digital Optimization

Boost mRNA Manufacturing with Digital Optimization

BIOT

📰 Researchers in Germany developed a digital model to optimize mRNA manufacturing, resulting in increased production and reduced truncation. 💻💉

featured image of FDA Releases Game-Changing CAR-T Guidelines: Everything You Need to Know!

FDA Releases Game-Changing CAR-T Guidelines: Everything You Need to Know!

BIOT

📢 The FDA published new guidance for CAR-T cell products, covering change management, risk assessment, flow cytometry, and more. 👩‍🔬🔬🧪🗂 CAR-T FDA

featured image of Robots and AI Revolutionize Cell and Gene Therapy Manufacturing!

Robots and AI Revolutionize Cell and Gene Therapy Manufacturing!

BIOT

🤖🔬 Researchers suggest that robots and AI can address manufacturing challenges in cell and gene therapy. ⬆️🌍 The industry is growing rapidly, requiring skilled personnel and increased production. 🤖🔬 Automation and AI can improve efficiency and reduce costs.

featured image of MilliporeSigma's €300 Million Investment Fuels South Korea's Bioproduction Boom

MilliporeSigma’s €300 Million Investment Fuels South Korea’s Bioproduction Boom

BIOT

📢 MilliporeSigma invests €300 million in South Korea bioproduction site, creating 300 jobs and supporting biotech and pharma industries. 🏭💼🧪🧬

featured image of Revolutionary Proteins Transform Nutrient Monitoring in Biopharma

Revolutionary Proteins Transform Nutrient Monitoring in Biopharma

BIOT

🔍 Researchers have developed a potential alternative technology for nutrient monitoring in biopharma using periplasmic binding proteins. 💡

featured image of Game-Changing Cancer Immunotherapy Deal Unveiled

Game-Changing Cancer Immunotherapy Deal Unveiled

BIOT

📰 Domain Therapeutics and Chime Biologics join forces to develop an anti-CCR8 antibody for cancer immunotherapy! 👥💉 Exciting times ahead! 🤝

featured image of Master Your Biopharma Strategy: Avoid Over-Investing

Master Your Biopharma Strategy: Avoid Over-Investing

BIOT

📢 Process intensification in biopharma is complex and costly, but with data-driven strategies and step-by-step implementation, success is possible! 💪💰📈

featured image of The High Costs of Low-Quality Albumin: Risks and Solutions

The High Costs of Low-Quality Albumin: Risks and Solutions

BIOT

1. 🚫💉 The Hidden Costs of Sub-standard Recombinant Albumin: Lost batches and patient risks in vaccines and biopharmaceuticals. 💰💊 2. The Hidden Costs of Sub-standard Recombinant Albumin: Safely lowering prices and broadening access to premium albumin. 💡💉🌾🔬🔍

featured image of Boosting Biopharmaceutical Manufacturing with Real-Time Control

Boosting Biopharmaceutical Manufacturing with Real-Time Control

BIOT

📰 Optimizing Critical Quality Attributes during Processing explores how a cyber-physical system and digital twin can improve biopharmaceutical manufacturing. 💊🔬🚀

featured image of Biopharma Struggles with Single-Use Standardization

Biopharma Struggles with Single-Use Standardization

BIOT

📰 Lack of Single-Use Standardization a Challenge for Biopharma: Industry struggles with flexibility, automation, and supplier dependency. 💊💼🔬